Back to Stakeholders
Categories

2 domains / 5 areas / 4 specializations

Government, Policy & Advocacy
Government, Policy & Advocacy
Policy Advocacy & ReformIndustry Associations & Lobby Groups
Regulation & EnforcementClinical Guideline Development Groups
Care Delivery & Psychedelic Facilitation
Care Delivery & Psychedelic Facilitation
Practitioner-Led Care OrganizationsProfessional Associations & Medical CollegesPsychiatry-Led Provider Organizations

American Psychiatric Association

Data updated

United States
2 Trials

US professional psychiatric body that publishes position statements and guidance relevant to evidence standards and clinical policy considerations for psychedelic and empathogenic therapies.

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

2
RecruitingII

Psilocybin Therapy for Psychological Distress in Palliative Patients (PsyPal)

Start Date
Compounds
Psilocybin
CompletedI

Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling

Start Date
Compounds
Ketamine